Animal models to study host-bacteria interactions involved in periodontitis

Frontiers of Oral Biology

Volumn 15, Issue , 2012, Pages 117-132

  Graves, Dana T ^a   Kang, Jun ^a,b   Andriankaja, Oelisoa ^a   Wada, Keisuke ^a   Rossa, Carlos ^c  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^b PEKING UNIVERSITY   (China)

^c Department of Diagnosis and Surgery   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ANIMAL; ANIMAL MODEL; BACTEROIDES; HOST PATHOGEN INTERACTION; HUMAN; IMMUNIZATION; IMMUNOLOGY; INJECTION; LIGATION; MANDIBLE; MICROBIOLOGY; MOUSE; ORAL DRUG ADMINISTRATION; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RAT; RAT STRAIN; REVIEW; SKULL; TREPONEMA DENTICOLA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADMINISTRATION, ORAL; ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNIZATION; INJECTIONS; LIGATION; LIPOPOLYSACCHARIDES; MANDIBLE; MICE; MODELS, ANIMAL; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RATS; RATS, INBRED STRAINS; SKULL; TREPONEMA DENTICOLA;

EID: 84855564530     PISSN: 14202433     EISSN: 16623770     Source Type: Book Series    
DOI: 10.1159/000329675     Document Type: Article

References (101)

1. Assuma R, Oates T, Cochran D, Amar S, Graves D: IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immun 1998;160:403-409. (Pubitemid 28116755)
2. Teng Y, Nguyen H, Gao X, Kong Y, Gorczynski R, Singh B, Ellen R, Penninger J: Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:R59-R67.
3. Baker P, Dixon M, Evans R, Dufour L, Johnson E, Roopenian D: CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999;67:2804-2809. (Pubitemid 29244693)
4. Delima A, Spyros K, Amar S, Graves DT: Inflammation and tissue loss caused by periodontal pathogens is reduced by IL-1 antagonists. J Infect Dis 2002;186:511-516. (Pubitemid 34876260)
5. Nowotny A, Sanavi F: Induction of nonspecific tolerance to endotoxins reduces the alveolar bone resorption in ligature-treated rats. Infect Immun1983; 39:873-878. (Pubitemid 13188371)
6. Bezerra MM, Brito GA, Ribeiro RA, Rocha FA: Low-dose doxycycline prevents inflammatory bone resorption in rats. Braz J Med Biol Res 2002;35:613-616. (Pubitemid 34568230)
7. Bezerra MM, de Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, Rocha FA: Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009-1014. (Pubitemid 30602322)
8. Lohinai Z, Benedek P, Feher E, Gyorfi A, Rosivall L, Fazekas A, Salzman AL, Szabo C: Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123: 353-360. (Pubitemid 28059703)
9. Xie R, Kuijpers-Jagtman AM, Maltha JC: Inflammatory responses in two commonly used rat models for experimental tooth movement: comparison with ligature-induced periodontitis. Arch Oral Biol 2011;56:159-167.
10. Nociti FH Jr, Nogueira-Filho GR, Tramontina VA, Machado MA, Barros SP, Sallum EA, Sallum AW: Histometric evaluation of the effect of nicotine administration on periodontal breakdown: an in vivo study. J Periodontal Res 2001;36:361-366. (Pubitemid 33633332)
11. Weiner GS, DeMarco TJ, Bissada NF: Long term effect of systemic tetracycline administration on the severity of induced periodontitis in the rat. J Periodontol 1979;50:619-623. (Pubitemid 10177345)
12. Rovin S, Costich ER, Gordon HA: The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J Periodontal Res 1966;1:193-204.
13. Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T: Observations on experimental marginal periodontitis in rats. J Periodontal Res 2004;39:101-106. (Pubitemid 39090090)
14. Kenworthy R, Baverel M: Studies of a periodontal tissue lesion in the rat, untreated or treated with chlorhexidine digluconate. J Clin Periodontol 1981; 8:349-358. (Pubitemid 11008409)
15. Luan Q, Desta T, Chehab L, Sanders VJ, Plattner J, Graves DT: Inhibition of experimental periodontitis by a topical boron-based antimicrobial. J Dent Res 2008;87:148-152.
16. Samejima Y, Ebisu S, Okada H: Effect of infection with Eikenella corrodens on the progression of ligature-induced periodontitis in rats. J Periodontal Res 1990;25:308-315. (Pubitemid 20329863)
17. Gyorfi A, Fazekas A, Suba Z, Ender F, Rosivall L: Neurogenic component in ligature-induced periodontitis in the rat. J Clin Periodontol 1994;21:601-605.
18. Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, Takai M, Ono Y, Taniguchi Y, Hara K: In vivo administration of IL-1 beta accelerates silk ligatureinduced alveolar bone resorption in rats. J Oral Pathol Med 1995;24:420-434.
19. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U: Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003;38:198-203. (Pubitemid 37485619)
20. Tomofuji T, Ekuni D, Irie K, Azuma T, Endo Y, Tamaki N, Sanbe T, Murakami J, Yamamoto T, Morita M: Preventive effects of a cocoa-enriched diet on gingival oxidative stress in experimental periodontitis. J Periodontol 2009;80:1799-1808.
21. Ekuni D, Tomofuji T, Irie K, Kasuyama K, Umakoshi M, Azuma T, Tamaki N, Sanbe T, Endo Y, Yamamoto T, Nishida T, Morita M: Effects of periodontitis on aortic insulin resistance in an obese rat model. Lab Invest 2010;90:348-359.
22. Endo Y, Tomofuji T, Ekuni D, Irie K, Azuma T, Tamaki N, Yamamoto T, Morita M: Experimental periodontitis induces gene expression of proinflammatory cytokines in liver and white adipose tissues in obesity. J Periodontol 2010;81:520-526.
23. Cesar Neto J, de Souza A, Barbieri D, Moreno HJ, Sallum EA, Nociti FH Jr: Matrix metalloproteinase-2 may be involved with increased bone loss associated with experimental periodontitis and smoking: a study in rats. J Periodontol 2004;75:995-1000. (Pubitemid 39162108)
24. Benatti BB, Nogueira-Filho GR, Diniz MC, Sallum EA, Sallum AW, Nociti FH Jr: Stress may enhance nicotine effects on periodontal tissues: an in vivo study in rats. J Periodontal Res 2003;38:351-353. (Pubitemid 37465572)
25. Clark J, Palmer C, Shaw W: The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 1983;173:68-75. (Pubitemid 13088195)
26. Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, Graves D: Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dental Res 2006;85:510-514. (Pubitemid 43945487)
27. Fine DH, Velliyagounder K, Furgang D, Kaplan JB: The Actinobacillus actinomycetemcomitans autotransporter adhesin Aae exhibits specificity for buccal epithelial cells from humans and old world primates. Infect Immun 2005;73:1947-1953. (Pubitemid 40470791)
28. Scannapieco FA, Millar SJ, Reynolds HS, Zambon JJ, Levine MJ: Effect of anaerobiosis on the surface ultrastructure and surface proteins of Actinobacillus actinomycetemcomitans (Haemophilus actinomycetemcomitans). Infect Immun 1987;55:2320-2323.
29. Fine DH, Goncharoff P, Schreiner H, Chang KM, Furgang D, Figurski D: Colonization and persistence of rough and smooth colony variants of Actinobacillus actinomycetemcomitans in the mouths of rats. Arch Oral Biol 2001;46:1065-1078. (Pubitemid 32963994)
30. Kachlany SC, Planet PJ, DeSalle R, Fine DH, Figurski DH: Genes for tight adherence of Actinobacillus actinomycetemcomitans: from plaque to plague to pond scum. Trends Microbiol 2001;9: 429-437. (Pubitemid 32844329)
31. Saito T, Ishihara K, Ryu M, Okuda K, Sakurai K: Fimbriae-associated genes are biofilm-forming factors in Aggregatibacter actinomycetemcomitans strains. Bull Tokyo Dent Coll 2010;51:145-150.
32. Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK: Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol 2010;25:275-292.
33. Klausen B, Evans RT, Ramamurthy NS, Golub LM, Sfintescu C, Lee JY, Bedi G, Zambon JJ, Genco RJ: Periodontal bone level and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis. Oral Microbiol Immunol 1991;6:193-201.
34. Chang KM, Ramamurthy NS, McNamara TF, Genco RJ, Golub LM: Infection with a gram-negative organism stimulates gingival collagenase production in non-diabetic and diabetic germfree rats. J Periodontal Res 1988;23:239-244.
35. Baker P, Evans R, Roopenian D: Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 1994; 39:1035-1040. (Pubitemid 124034593)
36. Baker PJ, Dixon M, Roopenian DC: Genetic control of susceptibility to Porphyromonas gingivalisinduced alveolar bone loss in mice. Infect Immun 2000;68:5864-5868.
37. Lalla E, Lamster I, Feit M, Huang L, Schmidt A: A murine model of accelerated periodontal disease in diabetes. J Periodontal Res 1998;33:387-399. (Pubitemid 128527122)
38. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS: Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006;21:12-20.
39. Sharma A, Inagaki S, Honma K, Sfintescu C, Baker PJ, Evans RT: Tannerella forsythia-induced alveolar bone loss in mice involves leucine-rich-repeat BspA protein. J Dent Res 2005;84:462-467. (Pubitemid 43827880)
40. Lee SF, Andrian E, Rowland E, Marquez IC: Immune response and alveolar bone resorption in a mouse model of Treponema denticola infection. Infect Immun 2009;77:694-698.
41. Bainbridge B, Verma RK, Eastman C, Yehia B, Rivera M, Moffatt C, Bhattacharyya I, Lamont RJ, Kesavalu L: Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. Infect Immun 2010;78:4560-4569.
42. Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, Ebersole JL: Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun 2007;75:1704-1712. (Pubitemid 46559435)
43. Baker PJ, Dixon M, Evans RT, Roopenian DC: Heterogeneity of Porphyromonas gingivalis strains in the induction of alveolar bone loss in mice. Oral Microbiol Immunol 2000;15:27-32. (Pubitemid 30065213)
44. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, Evans RT, Gaffen SL: An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007;109:3794-3802. (Pubitemid 46641730)
45. Okada Y, Hamada N, Kim Y, Takahashi Y, Sasaguri K, Ozono S, Sato S: Blockade of sympathetic b-receptors inhibits Porphyromonas gingivalis-induced alveolar bone loss in an experimental rat periodontitis model. Arch Oral Biol 2010;55:502-508.
46. Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS: Actinobacillus actinomycetemcomitansinduced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect 2005;7:738-747. (Pubitemid 40723645)
47. Nakamura H, Fukusaki Y, Yoshimura A, Shiraishi C, Kishimoto M, Kaneko T, Hara Y: Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo. Oral Microbiol Immunol 2008;23:190-195. (Pubitemid 351519448)
48. Gemmell E, Winning TA, Carter CL, Ford PJ, Bird PS, Ashman RB, Grieco DA, Seymour GJ: Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis. Oral Microbiol Immunol 2003;18:364-370. (Pubitemid 37372897)
49. Breivik T, Thrane PS, Gjermo P, Opstad PK, Pabst R, von Horsten S: Hypothalamic-pituitary-adrenal axis activation by experimental periodontal disease in rats. J Periodontal Res 2001;36:295-300. (Pubitemid 33641094)
50. Polak J, Hench L: Gene therapy progress and prospects: in tissue engineering. Gene Ther 2005;12: 1725-1733. (Pubitemid 41760285)
51. O'Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC: An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J Immunol 2005;175:3980-3989. (Pubitemid 41292060)
52. Gibson FC 3rd, Genco CA: Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun 2001;69:7959-7963. (Pubitemid 33086635)
53. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN, Schmidt AM: Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23: 1405-1411. (Pubitemid 36994529)
54. Gibson FC 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA: Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:2801-2806. (Pubitemid 38737928)
55. Wada K, Kamisaki Y: Roles of oral bacteria in cardiovascular diseases -from molecular mechanisms to clinical cases: involvement of Porphyromonas gingivalis in the development of human aortic aneurysm. J Pharmacol Sci 2010;113:115-119.
56. Dumitrescu AL, Abd-El-Aleem S, Morales-Aza B, Donaldson LF: A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol 2004;31:596-603. (Pubitemid 39092219)
57. Nishida E, Hara Y, Kaneko T, Ikeda Y, Ukai T, Kato I: Bone resorption and local interleukin-1alpha and interleukin-1beta synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 2001;36:1-8. (Pubitemid 33644624)
58. Buduneli E, Vardar-Sengul S, Buduneli N, Atilla G, Wahlgren J, Sorsa T: Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate. J Periodontol 2007;78:127-134. (Pubitemid 46195836)
59. Sartori R, Li F, Kirkwood KL: MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res 2009;88:1125-1130.
60. Nakamura H, Ukai T, Yoshimura A, Kozuka Y, Yoshioka H, Yoshinaga Y, Abe Y, Hara Y: Green tea catechin inhibits lipopolysaccharide-induced bone resorption in vivo. J Periodontal Res 2010;45:23-30.
61. Garcia de Aquino S, Manzolli Leite FR, Stach-Machado DR, Francisco da Silva JA, Spolidorio LC, Rossa C Jr: Signaling pathways associated with the expression of inflammatory mediators activated during the course of two models of experimental periodontitis. Life Sci 2009;84:745-754.
62. Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, Giannobile WV, Kirkwood KL: Actinobacillus actinomycetemcomitans lipopolysaccharide- mediated experimental bone loss model for aggressive periodontitis. J Periodontol 2007;78: 550-558.
63. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM: Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004;72:5041-5051. (Pubitemid 39223388)
64. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ: Activation of toll-like receptors 2 and 4 by gramnegative periodontal bacteria. Oral Microbiol Immunol 2007;22:145-151. (Pubitemid 46683962)
65. Burns E, Bachrach G, Shapira L, Nussbaum G: Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 2006;177:8296-8300. (Pubitemid 44893789)
66. Liu R, Desta T, Raptis M, Darveau RP, Graves DT: P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J Periodontol 2008;79:1241-1247.
67. Berezow AB, Ernst RK, Coats SR, Braham PH, Karimi-Naser LM, Darveau RP: The structurally similar, penta-acylated lipopolysaccharides of Porphyromonas gingivalis and Bacteroides elicit strikingly different innate immune responses. Microb Pathog 2009;47:68-77.
68. Boyce B, Aufdemorte T, Garrett I, Yates A, Mundy G: Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 1989;125:1142-1150. (Pubitemid 19223955)
69. Zubery Y, Dunstan C, Story B, Kesavalu L, Ebersole J, Holt S, Boyce B: Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect Immun 1998;66: 4158-4162. (Pubitemid 28402686)
70. Maitra R, Follenzi A, Yaghoobian A, Montagna C, Merlin S, Cannizzo ES, Hardin JA, Cobelli N, Stanley ER, Santambrogio L: Dendritic cell-mediated in vivo bone resorption. J Immunol 2010;185: 1485-1491.
71. Leone CW, Bokhadhoor H, Kuo D, Desta T, Yang J, Siqueira MF, Amar S, Graves DT: Immunization enhances inflammation and tissue destruction in response to Porphyromonas gingivalis. Infect Immun 2006;74:2286-2292.
72. Graves D, Oskoui M, Volejnikova S, Naguib G, Cai S, Desta T, Kakouras A, Jiang Y: Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 2001;80:1875-1879. (Pubitemid 33038053)
73. Graves D, Naguib G, Lu H, Desta T, Amar S: Porphyromonas gingivalis fimbriae are proinflammatory but do not play a prominent role in the innate immune response to P. gingivalis. J Endotoxin Res 2005;11:13-18. (Pubitemid 40533074)
74. He H, Liu R, Desta T, Leone C, Gerstenfeld L, Graves D: Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 2004;145:447-4 52.
75. Li L, Khansari A, Shapira L, Graves D, Amar S: Contribution of interleukin-11 and protaglandin(s) in lipopolysaccharide-induced bone resorption in vivo. Infect Immun 2002;70:3915-3922. (Pubitemid 34666032)
76. Liu R, Bal HS, Desta T, Behl Y, Graves DT: Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol 2006;168:757-764. (Pubitemid 43327728)
77. Nason R, Lee DH, Jung JY, Chole RA: Radiographic and micro-computed tomographic imaging of lipopolysaccharide-mediated bone resorption. Ann Otol Rhinol Laryngol 2009;118:391-396.
78. Battaglino R, Vokes M, Schulze-Spate U, Sharma A, Graves D, Kohler T, Muller R, Yoganathan S, Stashenko P: Fluoxetine treatment increases trabecular bone formation in mice. J Cell Biochem 2007; 100:1387-1394. (Pubitemid 46515573)
79. Bakthavatchalu V, Meka A, Sathishkumar S, Lopez MC, Verma RK, Wallet SM, Bhattacharyya I, Boyce BF, Mans JJ, Lamont RJ, Baker HV, Ebersole JL, Kesavalu L: Molecular characterization of Treponema denticola infection-induced bone and soft tissue transcriptional profiles. Mol Oral Micro biol 2010;25:260-274.
80. Meka A, Bakthavatchalu V, Sathishkumar S, Lopez MC, Verma RK, Wallet SM, Bhattacharyya I, Boyce BF, Handfield M, Lamont RJ, Baker HV, Ebersole JL, Kesavalu L: Porphyromonas gingivalis infectioninduced tissue and bone transcriptional profiles. Mol Oral Microbiol 2010;25:61-74.
81. Bakthavatchalu V, Meka A, Sathishkumar S, Lopez MC, Bhattacharyya I, Boyce BF, Mans JJ, Lamont RJ, Baker HV, Ebersole JL, Kesavalu L: Tannerella forsythia infection-induced calvarial bone and soft tissue transcriptional profiles. Mol Oral Microbiol 2010;25:317-330.
82. Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT: Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 2006;55:487-495. (Pubitemid 43343280)
83. Chiang C, Kyritsis G, Graves D, Amar S: Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 1999;67:4231-4236. (Pubitemid 29357050)
84. Li H, Suzuki J, Bayna E, Zhang F, Dalle M, Clark A, Engler R, Lew W: Lipopolysaccharide induces apoptosis in adult rat ventricular myocytes via cardiac AT(1) receptors. Am J Physiol Heart Circ Physiol 2002;282:H461-H467. (Pubitemid 34790836)
85. Liu R, Desta T, He H, Graves D: Diabetes alters the response to bacteria by enhancing fibroblast apoptosis. Endocrinology 2004;145:2997-3003. (Pubitemid 38686249)
86. Zappa U, Reinking-Zappa M, Graf H, Chase D: Cell populations associated with active probing attachment loss. J Periodontol 1992;63:748-752.
87. Behl Y, Siqueira M, Ortiz J, Li J, Desta T, Faibish D, Graves DT: Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol 2008;181:8711-8718.
88. Graves DT, Li J, Cochran DL: Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res 2011;90:143-153.
89. Dahlin C, Linde A, Gottlow J, Nyman S: Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg 1988;81:672-676.
90. Sandberg E, Dahlin C, Linde A: Bone regeneration by the osteopromotion technique using bioabsorbable membranes: an experimental study in rats. J Oral Maxillofac Surg 1993;51:1106-1114. (Pubitemid 23295424)
91. Bartee BK, Carr JA: Evaluation of a high-density polytetrafluoroethylene (n-PTFE) membrane as a barrier material to facilitate guided bone regeneration in the rat mandible. J Oral Implantol 1995;21: 88-95.
92. Deppe H, Stemberger A, Hillemanns M: Effects of osteopromotive and anti-infective membranes on bone regeneration: an experimental study in rat mandibular defects. Int J Oral Maxillofac Implants 2003;18:369-376. (Pubitemid 37141332)
93. Hirota M, Matsui Y, Mizuki N, Kishi T, Watanuki K, Ozawa T, Fukui T, Shoji S, Adachi M, Monden Y, Iwai T, Tohnai I: Combination with allogenic bone reduces early absorption of beta-tricalcium phosphate (beta-TCP) and enhances the role as a bone regeneration scaffold: experimental animal study in rat mandibular bone defects. Dent Mater J 2009;28: 153-161.
94. Hedner E, Linde A: Efficacy of bone morphogenetic protein (BMP) with osteopromotive membranes -an experimental study in rat mandibular defects. Eur J Oral Sci 1995;103:236-241.
95. Almeida JD, Arisawa EA, Balducci I, da Rocha RF, Carvalho YR: Homeopathic treatment for bone regeneration: experimental study. Homeopathy 2009;98:92-96.
96. Almeida JD, Arisawa EA, da Rocha RF, Carvalho YR: Effect of calcitonin on bone regeneration in male rats: a histomorphometric analysis. Int J Oral Maxillofac Surg 2007;36:435-440. (Pubitemid 46696676)
97. Schortinghuis J, Stegenga B, Raghoebar GM, de Bont LG: Ultrasound stimulation of maxillofacial bone healing. Crit Rev Oral Biol Med 2003;14:63-74.
98. Schortinghuis J, Ruben JL, Raghoebar GM, Stegenga B: Therapeutic ultrasound to stimulate osteoconduction: a placebo controlled single blind study using e-PTFE membranes in rats. Arch Oral Biol 2004;49:413-420. (Pubitemid 38431027)
99. Lu M, Rabie AB: Quantitative assessment of early healing of intramembranous and endochondral autogenous bone grafts using micro-computed tomography and Q-win image analyzer. Int J Oral Maxillofac Surg 2004;33:369-376. (Pubitemid 38779955)
100. Gielkens PF, Schortinghuis J, de Jong JR, Huysmans MC, Leeuwen MB, Raghoebar GM, Bos RR, Stegenga B: A comparison of micro-CT, microradiography and histomorphometry in bone research. Arch Oral Biol 2008;53:558-566.
101. Gielkens PF, Schortinghuis J, de Jong JR, Raghoebar GM, Stegenga B, Bos RR: Vivosorb, Bio-Gide, and Gore-Tex as barrier membranes in rat mandibular defects: an evaluation by microradiography and micro-CT. Clin Oral Implants Res 2008;19:516-521.